Laura Rodriguez Gallego

Bachelor of Science in Biotechnology (UAB), PhD in Biotechnology (UB) and a Postgraduate course in Innovation Management (UAB). Her research in gene therapy applications in the cancer field have led to publications in scientific journals and collaborations with biotech companies.

She has been Project Manager in the Knowledge Transfer and Innovation Unit at the Research Institute of the Vall d’Hebron Hospital (VHIR) in Barcelona. She is an active member in the EIT Health Alumni Network, after her participation in the EIT Health Innovation & Business Creation Summer School (2016) organized by the Trinity College in Dublin and IESE business school.

She usually collaborates with different entities of the health innovation ecosystem as a start-up mentor, jury and evaluator (COMB, EIT Health, Ship2b, Imagine IF!, FIPSE and CIMTI, among others).
Since January 2018, she works as investment analyst in Healthequity, and since 2019 at Invivo Ventures, the first fund of Invivo Capital Partners. Currently she is Principal at Invivo Capital Partners.